Dividend compounder review

KNSA

Kiniksa Pharmaceuticals Ltd · NASDAQ · US

Healthcare · Drug Manufacturers - Specialty & Generic

Chart Factor Intelligence Back to Screener
Score51.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 15.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 20.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 12.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$59.0M
Free Cash Flow$136.4M
FCF Covers DividendUnknown
Debt / Equity1.49
P/E57.0
Revenue Growth 5Y144.8%
Net Margin9.7%
ROE13.7%
Price vs Trend12.5%
3Y Return235.6%
5Y Return245.2%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

KNSA dividend review warning Warning · Warning

No usable dividend history found.